advanceCOR GmbH
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Holding
- Established
- 2012-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.advancecor.com
Revacept in Symptomatic Carotid Stenosis
Phase 2
Completed
- Conditions
- TIAStrokeAmaurosis FugaxCarotid StenosisAtherosclerosisTransient-ischaemic Attack
- Interventions
- Drug: PlaceboDrug: Revacept
- First Posted Date
- 2012-07-20
- Last Posted Date
- 2021-01-28
- Lead Sponsor
- AdvanceCor GmbH
- Target Recruit Count
- 158
- Registration Number
- NCT01645306
- Locations
- 🇩🇪
Site 08: Universitätsklinikum Essen, Klinik für Neurologie, Essen, Germany
🇩🇪Site 11: Universitätsklinikum Hamburg Eppendorf, Hamburg, Germany
🇩🇪Site 12: Universitätsklinikum Leipzig AöR, Leipzig, Germany
Safety, Pharmacokinetic and -Dynamic Study of PR-15, an Inhibitor of Platelet Adhesion
Phase 1
Completed
- Conditions
- ThrombosisAcute Coronary SyndromeMyocardial InfarctionStroke
- First Posted Date
- 2010-01-06
- Last Posted Date
- 2012-10-19
- Lead Sponsor
- AdvanceCor GmbH
- Target Recruit Count
- 30
- Registration Number
- NCT01042964
- Locations
- 🇩🇪
ABX-CRO/Medifacts GmbH, Goerlitz, Saxony, Germany
© Copyright 2025. All Rights Reserved by MedPath